PARIS (Reuters) - France's competition authority fined U.S. healthcare group Johnson & Johnson 25 million euros ($29.62 million) on Wednesday after it found the company had deliberately slowed market access to generic copies of its painkiller Durogesic.

France fines J&J 25 million euros over painkiller patch
Read More
Bagikan Berita Ini
0 Response to "France fines J&J 25 million euros over painkiller patch"
Posting Komentar